216 related articles for article (PubMed ID: 28945860)
1. The Role of Extent of Resection in IDH1 Wild-Type or Mutant Low-Grade Gliomas.
Patel T; Bander ED; Venn RA; Powell T; Cederquist GY; Schaefer PM; Puchi LA; Akhmerov A; Ogilvie S; Reiner AS; Moussazadeh N; Tabar V
Neurosurgery; 2018 Jun; 82(6):808-814. PubMed ID: 28945860
[TBL] [Abstract][Full Text] [Related]
2. Comparative volumetric analysis of the extent of resection of molecularly and histologically distinct low grade gliomas and its role on survival.
Eseonu CI; Eguia F; ReFaey K; Garcia O; Rodriguez FJ; Chaichana K; Quinones-Hinojosa A
J Neurooncol; 2017 Aug; 134(1):65-74. PubMed ID: 28527004
[TBL] [Abstract][Full Text] [Related]
3. The Role of Surgery in IDH-Wild-Type Lower-Grade Gliomas: Threshold at a High Extent of Resection Should be Pursued.
Wang P; Luo C; Hong PJ; Rui WT; Wu S
Neurosurgery; 2021 May; 88(6):1136-1144. PubMed ID: 33647953
[TBL] [Abstract][Full Text] [Related]
4. Association of supratotal resection with progression-free survival, malignant transformation, and overall survival in lower-grade gliomas.
Rossi M; Gay L; Ambrogi F; Conti Nibali M; Sciortino T; Puglisi G; Leonetti A; Mocellini C; Caroli M; Cordera S; Simonelli M; Pessina F; Navarria P; Pace A; Soffietti R; Rudà R; Riva M; Bello L
Neuro Oncol; 2021 May; 23(5):812-826. PubMed ID: 33049063
[TBL] [Abstract][Full Text] [Related]
5. Genomic Prognosticators and Extent of Resection in Molecularly Subtyped World Health Organization Grade II and III Gliomas-A Single-Institution, Nine-Year Data.
Lasica AB; Jaunmuktane Z; Fersht N; Kirkman MA; Dixon L; Hoskote C; Brandner S; Samandouras G
World Neurosurg; 2021 Jul; 151():e217-e233. PubMed ID: 33866029
[TBL] [Abstract][Full Text] [Related]
6. Insular glioma resection: assessment of patient morbidity, survival, and tumor progression.
Sanai N; Polley MY; Berger MS
J Neurosurg; 2010 Jan; 112(1):1-9. PubMed ID: 19612970
[TBL] [Abstract][Full Text] [Related]
7. Threshold of the extent of resection for WHO Grade III gliomas: retrospective volumetric analysis of 122 cases using intraoperative MRI.
Fujii Y; Muragaki Y; Maruyama T; Nitta M; Saito T; Ikuta S; Iseki H; Hongo K; Kawamata T
J Neurosurg; 2018 Jul; 129(1):1-9. PubMed ID: 28885120
[TBL] [Abstract][Full Text] [Related]
8. An extent of resection threshold for seizure freedom in patients with low-grade gliomas.
Xu DS; Awad AW; Mehalechko C; Wilson JR; Ashby LS; Coons SW; Sanai N
J Neurosurg; 2018 Apr; 128(4):1084-1090. PubMed ID: 28548599
[TBL] [Abstract][Full Text] [Related]
9. Surgery for Diffuse WHO Grade II Gliomas: Volumetric Analysis of a Multicenter Retrospective Cohort From the German Study Group for Intraoperative Magnetic Resonance Imaging.
Scherer M; Ahmeti H; Roder C; Gessler F; Jungk C; Pala A; Mayer B; Senft C; Tatagiba M; Synowitz M; Wirtz CR; Unterberg AW; Coburger J
Neurosurgery; 2020 Jan; 86(1):E64-E74. PubMed ID: 31574147
[TBL] [Abstract][Full Text] [Related]
10. Low-grade glioma surgery in eloquent areas: volumetric analysis of extent of resection and its impact on overall survival. A single-institution experience in 190 patients: clinical article.
Ius T; Isola M; Budai R; Pauletto G; Tomasino B; Fadiga L; Skrap M
J Neurosurg; 2012 Dec; 117(6):1039-52. PubMed ID: 23039150
[TBL] [Abstract][Full Text] [Related]
11. Isocitrate Dehydrogenase Mutations in Low-Grade Gliomas Correlate With Prolonged Overall Survival in Older Patients.
Jones PS; Carroll KT; Koch M; DiCesare JAT; Reitz K; Frosch M; Barker FG; Cahill DP; Curry WT
Neurosurgery; 2019 Feb; 84(2):519-528. PubMed ID: 29846690
[TBL] [Abstract][Full Text] [Related]
12. Risk Factors for Progression Among Low-Grade Gliomas After Gross Total Resection and Initial Observation in the Molecular Era.
Tom MC; Varra V; Leyrer CM; Park DY; Chao ST; Yu JS; Suh JH; Reddy CA; Balagamwala EH; Broughman JR; Kotagal KA; Vogelbaum MA; Barnett GH; Ahluwalia MS; Peereboom DM; Prayson RA; Stevens GHJ; Murphy ES
Int J Radiat Oncol Biol Phys; 2019 Aug; 104(5):1099-1105. PubMed ID: 31022510
[TBL] [Abstract][Full Text] [Related]
13. Volumetric Analysis of Extent of Resection, Survival, and Surgical Outcomes for Insular Gliomas.
Eseonu CI; ReFaey K; Garcia O; Raghuraman G; Quinones-Hinojosa A
World Neurosurg; 2017 Jul; 103():265-274. PubMed ID: 28408263
[TBL] [Abstract][Full Text] [Related]
14. Extent of Surgical Resection in Lower-Grade Gliomas: Differential Impact Based on Molecular Subtype.
Patel SH; Bansal AG; Young EB; Batchala PP; Patrie JT; Lopes MB; Jain R; Fadul CE; Schiff D
AJNR Am J Neuroradiol; 2019 Jul; 40(7):1149-1155. PubMed ID: 31248860
[TBL] [Abstract][Full Text] [Related]
15. Rethinking extent of resection of contrast-enhancing and non-enhancing tumor: different survival impacts on adult-type diffuse gliomas in 2021 World Health Organization classification.
Park YW; Kim S; Han K; Ahn SS; Moon JH; Kim EH; Kim J; Kang SG; Kim SH; Lee SK; Chang JH
Eur Radiol; 2024 Feb; 34(2):1376-1387. PubMed ID: 37608093
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of the extent of resection in supratentorial WHO grade II astrocytomas stratified for IDH1 mutation status: a single-center volumetric analysis.
Jungk C; Scherer M; Mock A; Capper D; Radbruch A; von Deimling A; Bendszus M; Herold-Mende C; Unterberg A
J Neurooncol; 2016 Sep; 129(2):319-28. PubMed ID: 27344556
[TBL] [Abstract][Full Text] [Related]
17. Proposed therapeutic strategy for adult low-grade glioma based on aggressive tumor resection.
Nitta M; Muragaki Y; Maruyama T; Ikuta S; Komori T; Maebayashi K; Iseki H; Tamura M; Saito T; Okamoto S; Chernov M; Hayashi M; Okada Y
Neurosurg Focus; 2015 Jan; 38(1):E7. PubMed ID: 25599276
[TBL] [Abstract][Full Text] [Related]
18. Intraoperative 3D ultrasound-guided resection of diffuse low-grade gliomas: radiological and clinical results.
Bø HK; Solheim O; Kvistad KA; Berntsen EM; Torp SH; Skjulsvik AJ; Reinertsen I; Iversen DH; Unsgård G; Jakola AS
J Neurosurg; 2019 Feb; 132(2):518-529. PubMed ID: 30717057
[TBL] [Abstract][Full Text] [Related]
19. Transcortical insular glioma resection: clinical outcome and predictors.
Hameed NUF; Qiu T; Zhuang D; Lu J; Yu Z; Wu S; Wu B; Zhu F; Song Y; Chen H; Wu J
J Neurosurg; 2018 Oct; 131(3):706-716. PubMed ID: 30485243
[TBL] [Abstract][Full Text] [Related]
20. Impact of gross total resection in patients with WHO grade III glioma harboring the IDH 1/2 mutation without the 1p/19q co-deletion.
Kawaguchi T; Sonoda Y; Shibahara I; Saito R; Kanamori M; Kumabe T; Tominaga T
J Neurooncol; 2016 Sep; 129(3):505-514. PubMed ID: 27401154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
